As a celebration of #GynaecologicalCancerAwarenessMonth and ANZGOG’s 20th year anniversary, we asked ANZGOG’s Inaugural Chair and Co-Founder, Professor Michael Friedlander AM, to share the tales of how and why ANZGOG originated, more about the world-first basket [...]
Awarded a $2m Medical Research Future Fund government grant for the PARAGON-II study, Principal Investigator Associate Professor Chee Lee speaks about the study aims. The study follows on from PARAGON, an ANZGOG trial that pioneered [...]
The ANZGOG-led trial known as AtTEnd will engage patients with advanced endometrial cancer and will incorporate additional immune therapy into existing chemotherapy treatment. Assoc Prof Yoland Antill The coordinating Principal Investigator of [...]
To celebrate #GynaecologicalCancerAwarenessMonth and ANZGOG’s 20th year anniversary, Professor Michael Quinn AM tells us the story of ANZGOG's beginnings, his fundraising highlights, and shares his advice to young gynaecological cancer researchers... As a founding [...]
Through ANZGOG the PRECISE trial will engage with high grade serous ovarian cancer (HGSOC) patients who are found to possess reactivated cancer cells after treatment. This is a common occurrence, as most HGSOC patients [...]
ANZGOG has united with Ovarian Cancer Australia and the Australian Society of Gynaecologic Oncologists (ASGO) to launch the Ovarian Cancer National Action Plan (NAP) 2020 – 2025. The NAP sets out a roadmap for [...]
ANZGOG congratulates Member Prof Anna DeFazio and former Survivors Teaching Students volunteer Kristen Larsen for being awarded the 2020 Jeannie Ferris Cancer Australia Recognition Award. Both Prof DeFazio and Ms Larsen were recognised for their significant [...]
“We now know that women with the most common types of ovarian cancer should be offered genetic testing, irrespective of family history. So that's a significant change in the Australian guidelines and guidelines elsewhere. PARP inhibitors have [...]
Congratulations to ANZGOG Member Assoc Prof Pamela Pollock, whos pre clinical study into endometrial cancer has been awarded Perpetual grant funding. Here's what Assoc Prof Pollock had to say about the news: A/Prof [...]
ANZGOG congratulates its members Prof Linda Mileshkin, A/Prof Rhonda Farrell, and A/Prof Chee Khoon Lee for their successful MRFF grant initiatives in reproductive and gynaecological cancers. $6.5 million in funding will be invested by the [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2025 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
